Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment
about
Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Prevalence and Associated Fact ...... Disoproxil Fumarate Treatment
@en
type
label
Prevalence and Associated Fact ...... Disoproxil Fumarate Treatment
@en
prefLabel
Prevalence and Associated Fact ...... Disoproxil Fumarate Treatment
@en
P2093
P356
P1476
Prevalence and Associated Fact ...... Disoproxil Fumarate Treatment
@en
P2093
Adriana Ammassari
Andrea Antinori
Anna Loredana Gallo
Carmela Pinnetti
Chiara Tommasi
Claudio Angeletti
Emanuele Nicastri
Maria Letizia Giancola
Martina Ricottini
Mauro Zaccarelli
P304
P356
10.1089/AID.2018.0074
P577
2018-07-23T00:00:00Z